Indraprastha Apollo Hospital Delhi

Indraprastha Apollo Hospitals in New Delhi is the flagship facility of Apollo Hospitals Group — India's largest hospital network — and one of the most internationally recognised hospitals in Asia. Spread over 12 acres with a built-up area of 600,000 square feet, it was founded in 1996 as a joint venture between Apollo Hospitals Group and the Government of Delhi, at a cost of USD 44 million. The hospital handles approximately 200,000 patients annually, of whom 12,000 are international patients from the USA, UK, Europe, Middle East, Africa, Australia, and CIS countries. It was the first Indian hospital to be awarded the gold-standard JCI certification from the Joint Commission International, USA. Indraprastha Apollo is part of Apollo Hospitals Enterprise Ltd, one of Asia's largest integrated healthcare groups. The Delhi facility handles approximately 200,000 patients annually — including over 12,000 international patients — performing more than 25,000 surgical procedures each year. The hospital has been involved in numerous medical firsts and has trained hundreds of super-specialty physicians through its DNB and fellowship programmes. Its comprehensive quaternary care capability makes it the first point of referral for the most complex cases from across North India, Nepal, Afghanistan, and neighbouring countries.

Indraprastha Apollo Hospital houses the country's leading programmes in cardiac surgery and interventional cardiology, organ transplantation (liver, kidney, heart, lung, bone marrow), oncology (surgical, medical, and radiation), neurosciences (neurosurgery, neurology, stroke care), orthopaedics and joint replacement, spine surgery, gastroenterology and GI surgery, nephrology, urology, pulmonology, obstetrics and gynaecology, infertility and IVF, paediatrics and neonatology, and emergency medicine. The hospital also has a renowned Proton Therapy Centre for cancer treatment. The Proton Therapy Centre is among a small number of facilities in India offering proton beam radiotherapy for cancer — a precision radiation modality that minimises damage to surrounding healthy tissue, particularly relevant for paediatric cancers and tumours adjacent to critical structures. The liver transplant programme is one of India's highest-volume programmes, with cadaveric and living-donor liver transplants performed regularly. The Institute of Orthopaedics covers primary and revision joint replacement, complex fracture management, paediatric orthopaedics, and spine surgery using robotic-assisted and minimally invasive techniques.

The hospital has 560 beds including 140 ICU beds and 44 High Dependency Unit (HDU) beds, 14 modular operation theatres, multiple cardiac catheterisation labs, a Proton Therapy Centre for cancer, advanced 3T MRI, 256-slice CT, PET-CT, robotic surgery platforms (da Vinci), LINAC radiation therapy, a comprehensive endoscopy suite, hybrid operating theatre, transplant surgery suites, a full-service blood bank, a molecular diagnostics laboratory, and a 24-hour emergency department with in-house specialists across all departments. The da Vinci robotic surgery platform supports minimally invasive procedures in urology, gynaecology, and general surgery. The hybrid operating theatre combines surgical and interventional radiology capabilities in a single room, enabling complex cardiovascular and neuro-interventional procedures. A comprehensive outpatient diagnostic imaging centre with 256-slice CT and 3T MRI provides rapid diagnostic turnaround for both inpatient and outpatient referrals.

Indraprastha Apollo Hospitals has a dedicated international patient services division with multilingual coordinators experienced in managing patients from over 120 countries. Services include pre-arrival telemedicine consultations, medical visa invitation letters, airport transfers, dedicated international patient lounges, currency exchange, global insurance acceptance, language interpretation, dietary accommodation, onsite hotels and guest houses, and post-discharge telemedicine follow-up. International patients come for cardiac, oncology, orthopaedic, transplant, and neuroscience procedures — benefiting from treatment costs 60-80% lower than equivalent care in Western countries. The international patient services division employs multilingual case managers proficient in Arabic, French, Russian, Swahili, and other languages, supporting the diverse international patient population. Dedicated international patient lounges, VIP admission pathways, and a 24-hour international helpline facilitate seamless access to the hospital's services for patients arriving from overseas.

Indraprastha Apollo Hospitals was the first Indian hospital to receive JCI (Joint Commission International) certification — the gold standard in global hospital quality accreditation, awarded by the US-based Joint Commission. The hospital also holds NABH accreditation and has been consistently rated among the best multi-specialty private hospitals in Delhi. These accreditations affirm the hospital's standards in patient safety, clinical quality, infection control, and patient rights. Indraprastha Apollo's JCI accreditation is periodically renewed following on-site assessment by Joint Commission International surveyors — confirming sustained compliance with international standards in clinical care delivery, infection prevention, facility management, and patient rights. The hospital is empanelled with over 50 insurance companies and government schemes.